Caprihans India Q1 FY27: PAT turns positive at Rs 7.01 Cr, revenue up 24% YoY

Emphasis Of MatterRevenue Growth 20pctPat Growth 25pctResults View source PDF Explain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+17.5%Reaction day

₹79.00

prior close

₹86.90

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used-0.2%+17.7% vs market

Plastic Products - Industrial peers, median of 39sector+0.0%+17.5% vs sector

On the reaction day the stock moved 17.7 pts more than Nifty Microcap 250 and 17.5 pts more than its Plastic Products - Industrial peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+6.8

10m

+6.8

15m

+6.8

30m

+6.8

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+17.5-0.2+17.7+0.0+17.5

Next day

+29.1+0.2+28.9+0.0+29.1

+26.6+0.4+26.2+0.4+26.2

+32.3+0.4+31.9+1.2+31.1

+45.6+0.6+45.0+0.0+45.6

+60.1+0.9+59.1-0.2+60.2

+72.2+0.9+71.3+1.0+71.2

15d

+38.0+0.9+37.0+2.2+35.8

+50.4+2.3+48.0-1.1+51.5

+27.7-1.1+28.8-2.0+29.7

—————

UpDownMarket · Nifty Microcap 250Sector · Plastic Products - Industrial peers, median of 39Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Caprihans India Q1 FY27: Standalone revenue rose 23.7% YoY to Rs 220.16 Cr; PAT turned positive at Rs 7.01 Cr vs a loss of Rs 13.55 Cr in Q1 FY26. PBT was Rs 7.01 Cr. Consolidated revenue was Rs 221.39 Cr with PAT of Rs 6.22 Cr. Basic EPS at Rs 4.25 vs negative Rs 9.27. Independent Director Avinash Joshi resigned for personal reasons. Auditor issued clean review with emphasis on legacy PFD arrangement with Bilcare, now transferred to IEPF. Company revalued PPE, adding Rs 21.03 Cr to revaluation reserve, and redeemed preference shares.

Likely market impact

Strong YoY turnaround from losses to profit with healthy revenue growth; positive for sentiment despite director exit and legacy PFD caveat.